featured
Cystic Fibrosis Transmembrane Conductance Regulator Modulator Use and Reduced Pancreatitis Hospitalizations in Patients With Cystic Fibrosis
Sign in to PracticeUpdate
Only registered members have full access to PracticeUpdate content.
Additional Info
Disclosure statements are available on the authors' profiles:
The American Journal of Gastroenterology
From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.
Cystic Fibrosis Transmembrane Conductance Regulator Modulator Use Is Associated With Reduced Pancreatitis Hospitalizations in Patients With Cystic Fibrosis
Am. J. Gastroenterol 2021 Oct 19;[EPub Ahead of Print], ML Ramsey, Y Gokun, LA Sobotka, MR Wellner, K Porter, SE Kirkby, SS Li, GI Papachristou, SG Krishna, PP Stanich, PA Hart, DL Conwell, LF LaraFrom MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.